SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-14-001810
Filing Date
2014-04-23
Accepted
2014-04-23 15:48:36
Documents
4
Period of Report
2014-06-05
Effectiveness Date
2014-04-23

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a_042314.htm DEF 14A 757740
2 cheung_sig.jpg GRAPHIC 4499
3 proxy_1.jpg GRAPHIC 200140
4 proxy_2.jpg GRAPHIC 143480
  Complete submission text file 0001171843-14-001810.txt   1238940
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14027 | Film No.: 14778738
SIC: 3841 Surgical & Medical Instruments & Apparatus